CoreAge Rx review
Semaglutide is advertised at $99 a month, on a row checked earlier than the rest of this group.
The verdict
CoreAge Rx advertises compounded semaglutide at $99 a month and compounded tirzepatide at $149, both injectable, which are low figures in this category, though the reading behind them is the oldest of the sellers wired here.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- $99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
CoreAge Rx sells compounded semaglutide and compounded tirzepatide as weekly injections through an online service, and it advertises $99 for the semaglutide and $149 for the tirzepatide. No oral form is listed for either molecule. All fifty states are served.
Who writes the prescription, and what do they see?
The service arranges treatment remotely and a prescription is issued before anything ships, but the page states the rates rather than describing the clinician who writes for them, and what an intake asks beforehand is not something the seller publishes.
Everything here is compounded and the service runs at a distance, with two products rather than four, so there is less to compare than at sellers offering both forms. The narrower catalog is not in itself a weakness; it does mean a reader who wants an oral will have to look elsewhere.
What happens when the dose goes up?
Neither rate carries a statement about what happens as the dose rises. Escalation across the first sixteen weeks is the normal path, so a reader should treat $99 as a starting figure rather than an annual one until the intake confirms otherwise.
What the price includes
The two advertised figures are $99 and $149, and the $50 between them is a narrower gap than this category usually puts between the molecules. The qualification worth carrying is the date: these figures were checked roughly ten days before the others in this group, so it is the one most likely to have moved since. A price with an older verification date is not wrong, but it is the first one to re-check.
What it claims, and what it cites
Both products are compounded preparations made by a pharmacy rather than finished products manufactured and reviewed by the FDA, which means neither is approved and neither is assessed for safety, efficacy or quality before it is dispensed. The trial evidence quoted for these molecules was generated with the approved products at labeled doses, and whether a compounded vial matches them in content or purity is not measured.
Where it holds up, and where it does not
- Strength: Lowest advertised figures of the sellers wired here
- Strength: Narrow $50 gap between the two molecules
- Strength: All fifty states served
- Limitation: No oral form for either molecule
- Limitation: Prices carry the oldest check date in this group
- Limitation: Dose-escalation pricing not stated
What the evidence says about this kind of treatment
The assessment above is about CoreAge Rx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader starting at a low dose, which is the tier these advertised rates are quoted against.
- Wrong for
- A reader who needs an oral, and a reader who wants the most recently verified figure on the page.
How CoreAge Rx compares
| Seller | Who it suits | Go |
|---|---|---|
| A reader who wants to try an oral before committing to injections, since both molecules are offered in both forms at a stated rate. | See Strut Health → | |
| A reader choosing between the two molecules on grounds other than price, since this seller charges the same for both. | See Care Bare Rx → | |
| A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form. | See Synergy Rx → |
More GLP-1 telehealth sellers reviews: Wholesome ClinicZera HealthBreeze MedsAlan MedsAlloyApex MD
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $99 a month current?
- CoreAge Rx advertises it, and its figures carry an earlier check date than the rest of this group. That is an earlier date than the other sellers in this group carry, so it is the figure most worth confirming on the seller's own page before you act on it.
- Can I get tirzepatide as a tablet here?
- No. Both molecules are sold as weekly injections and no oral line is advertised.
- Why is the gap between the molecules so small?
- Tirzepatide usually carries a larger premium over semaglutide than the $50 charged here, CoreAge Rx publishes the two figures and no explanation for the gap between them.
- Is CoreAge Rx expensive compared with other GLP-1 telehealth sellers?
- CoreAge Rx publishes a starting figure of $99/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts CoreAge Rx below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.